NCT00099021 2022-02-11
Pioglitazone Hydrochloride in Preventing Head and Neck Cancer in Patients With Oral Leukoplakia
National Cancer Institute (NCI)
Phase 2 Completed
National Cancer Institute (NCI)
University of Texas Southwestern Medical Center
University of Rochester
Khyber Medical University Peshawar
Takeda
The University of Texas Health Science Center at San Antonio